Therapeutic use of VEGF-C and CCBE1

Research output: PatentScientific

Abstract

The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.
Original languageEnglish
Publication Year19 Feb 2015
Publication statusPublished - 19 Feb 2015
MoE publication typeH1 Granted patent

Fields of Science

  • 3111 Biomedicine

Cite this

@misc{30eb885ad8db4ddda2b3efce05d8e270,
title = "Therapeutic use of VEGF-C and CCBE1",
abstract = "The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.",
keywords = "3111 Biomedicine",
author = "Kari Alitalo and Michael Jeltsch and Andrey Anisimov",
year = "2015",
month = "2",
day = "19",
language = "English",
publisher = "WIPO",
address = "Switzerland",
type = "Patent",
note = "WO2015/022447",

}

Therapeutic use of VEGF-C and CCBE1. / Alitalo, Kari ; Jeltsch, Michael; Anisimov, Andrey.

WIPO. Patent No.: WO2015/022447. Feb 15, 2015.

Research output: PatentScientific

TY - PAT

T1 - Therapeutic use of VEGF-C and CCBE1

AU - Alitalo, Kari

AU - Jeltsch, Michael

AU - Anisimov, Andrey

PY - 2015/2/19

Y1 - 2015/2/19

N2 - The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.

AB - The present invention relates to therapeutic methods, us- es and compositions comprising CCBE1 and VEGF-C for treating disorders and conditions involving impaired lymphatic system, particularly lymphedema.

KW - 3111 Biomedicine

UR - https://worldwide.espacenet.com/publicationDetails/biblio?CC=WO&NR=2015022447&KC=&FT=E&locale=en_EP#

M3 - Patent

M1 - WO2015/022447

Y2 - 2015/02/15

PB - WIPO

ER -